Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval)
OVERVIEW
SERIAL NUMBER	87320921	FILING DATE	02/01/2017
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	THOMAS-RIGGS, LESLIE A	L.O. ASSIGNED	N70-NOT FOUND

PUB INFORMATION
RUN DATE	10/10/2019
PUB DATE	06/06/2017
STATUS	819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE	10/09/2019
LITERAL MARK ELEMENT	RINVOQ
DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	YES	1 (a)	NO
1 (b)	YES	1 (b)	NO	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	RINVOQ
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	AbbVie Biotechnology Ltd.
ADDRESS	Clarendon House 2 Church Street Hamilton, HM11
ENTITY	03-CORPORATION
CITIZENSHIP	Bermuda

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	08/16/2019	FIRST USE IN COMMERCE DATE	08/16/2019	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
10/10/2019	SUNA	E	NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED	030
10/09/2019	CNPR	P	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	029
09/21/2019	SUPC	I	STATEMENT OF USE PROCESSING COMPLETE	028
08/29/2019	IUAF	S	USE AMENDMENT FILED	027
09/21/2019	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	026
08/29/2019	EISU	I	TEAS STATEMENT OF USE RECEIVED	025
07/27/2019	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	024
07/25/2019	EX4G	S	EXTENSION 4 GRANTED	023
07/25/2019	EXT4	S	EXTENSION 4 FILED	022
07/25/2019	EEXT	I	TEAS EXTENSION RECEIVED	021
02/02/2019	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	020
01/31/2019	EX3G	S	EXTENSION 3 GRANTED	019
01/31/2019	EXT3	S	EXTENSION 3 FILED	018
01/31/2019	EEXT	I	TEAS EXTENSION RECEIVED	017
08/01/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	016
07/30/2018	EX2G	S	EXTENSION 2 GRANTED	015
07/30/2018	EXT2	S	EXTENSION 2 FILED	014
07/30/2018	EEXT	I	TEAS EXTENSION RECEIVED	013
01/25/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	012
01/23/2018	EX1G	S	EXTENSION 1 GRANTED	011
01/23/2018	EXT1	S	EXTENSION 1 FILED	010
01/23/2018	EEXT	I	TEAS EXTENSION RECEIVED	009
08/01/2017	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	008
06/06/2017	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	007
06/06/2017	PUBO	A	PUBLISHED FOR OPPOSITION	006
05/17/2017	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	005
05/04/2017	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	004
04/27/2017	DOCK	D	ASSIGNED TO EXAMINER	003
02/06/2017	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
02/04/2017	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Cheryl A. Withycombe
CORRESPONDENCE ADDRESS	CHERYL A. WITHYCOMBE ABBVIE INC. V377/AP34-2 1 NORTH WAUKEGAN ROAD NORTH CHICAGO, IL 60064
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	AbbVie Biotechnology Ltd.
ADDRESS	Clarendon House 2 Church Street Hamilton, HM11
ENTITY	03-CORPORATION
CITIZENSHIP	Bermuda